Nikolina Vlatković

Medicine · Health Sciences

20h-index997citations44works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer-related Molecular Pathways(25), Epigenetics and DNA Methylation(9), Ubiquitin and proteasome pathways(7), RNA modifications and cancer(6), Cancer, Hypoxia, and Metabolism(5)

Publications44 total

Supplementary Figure 1 from MDM2 Regulates Dihydrofolate Reductase Activity through Monoubiquitination
2023Open Access
Supplementary Figure 2 from MDM2 Regulates Dihydrofolate Reductase Activity through Monoubiquitination
2023Open Access
Data from MDM2 Regulates Dihydrofolate Reductase Activity through Monoubiquitination
2023Open Access
Supplementary Figure 2 from MDM2 Regulates Dihydrofolate Reductase Activity through Monoubiquitination
2023Open Access
Data from MDM2 Regulates Dihydrofolate Reductase Activity through Monoubiquitination
2023Open Access
Supplementary Figure 1 from MDM2 Regulates Dihydrofolate Reductase Activity through Monoubiquitination
2023Open Access
Metabolic Plasticity and Combinatorial Radiosensitisation Strategies in Human Papillomavirus-Positive Squamous Cell Carcinoma of the Head and Neck Cell Lines
Cancers·2021· 9 citedOpen Access
P-13 Metabolism and Anti-Metabolic Therapeutic Strategies in Human Papillomavirus-Positive Squamous Cell Carcinoma of the Head and Neck
Oral Oncology·2021
Abstract 1620: MDM2 P1 and P2 promoters have different roles in tumorigenesis
Cancer Research·2020
A novel transgenic mouse strain expressing PKCβII demonstrates expansion of B1 and marginal zone B cell populations
Scientific Reports·2020· 9 citedOpen Access
TP53 mutations in head and neck cancer cells determine the Warburg phenotypic switch creating metabolic vulnerabilities and therapeutic opportunities for stratified therapies
Cancer Letters·2020· 20 citedOpen Access
Metabolic signature of squamous cell carcinoma of the head and neck: Consequences of TP53 mutation and therapeutic perspectives
Oral Oncology·2018· 20 cited
Tumour metabolism in squamous cell carcinoma of the head and neck: an in-vitro study of the consequences of TP53 mutation and therapeutic implications
The Lancet·2015· 13 cited
Janus-faces of NME–oncoprotein interactions
Naunyn-Schmiedeberg s Archives of Pharmacology·2014· 15 cited
Senescence induction in renal carcinoma cells by Nutlin-3: a potential therapeutic strategy based on MDM2 antagonism
Cancer Letters·2014· 20 citedOpen Access
Expression of human cationic trypsinogen (PRSS1) in murine acinar cells promotes pancreatitis and apoptotic cell death
Cell Death and Disease·2014· 41 citedOpen Access
Nucleolar control of p53: a cellular Achilles’ heel and a target for cancer therapy
Cellular and Molecular Life Sciences·2013· 51 citedOpen Access
Abstract 5057: Activation of stroma-derived matrix metalloproteinases (MMPs) in a model of gastric cancer.
Cancer Research·2013
The unfolded protein response regulator GRP78 is a novel predictive biomarker in colorectal cancer
International Journal of Cancer·2013· 54 citedOpen Access
Activation of stroma-derived matrix metalloproteinases (MMPs) in a model of gastric cancer
Cancer Research·2013
page 1 of 3Next →

Frequent Co-authors

Mark T. Boyd(34), Radosław Polański(13), Timothy Devling(11), Carlos P. Rubbi(11), Maria Maguire(9), Paul C. Nield(8), Rosalind E. Jenkins(8), Terence M. Jones(7), B. Kevin Park(7), Keith Parsons(5), Andrea Varró(5), Mark D. Wilkie(5), Andrew Lau(5), Aidan P. Noon(4), Fiona Campbell(4), Graham J. Dockray(4), Arpita Ray‐Sinha(3), Suzanne Lyons(3), R. Dimaline(3), Howida Shawki(2)